| 标题 |
 Abstract PS1-11-15: Current and future use of oral selective estrogen receptor degraders (SERDs) in the management of ER-positive (ER+), HER2-negative (HER2-neg) metastatic breast cancer (mBC): A survey of 20 breast cancer research leaders (RLs) |
| 网址 | |
| DOI |
10.1158/1557-3265.sabcs25-ps1-11-15
doi
|
| 其它 |
期刊：Clinical Cancer Research 作者：K. H. Pang; K. A. Ziel; D. Paley; S. A. Wander; M. R. Lloyd; et al 出版日期：2026-02-17 |
| 求助人 | |
| 下载 | 暂无链接，等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Sledge
mellow
cdercder
Nole
XX
leery
aajhajkahna
Criminology34
Kao
Dong021
GingerF
OK
无极微光
Logan
null
lili
xzy998
独特的项链
谪仙
mmyhn
有人
W sir
皖公网安备34019202002308
